# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-26T11:54:46.424882

---

**Idea Fidelity**

The paper adheres closely to the original idea manifest. It leverages the staggered transposition of Directive 2014/41/EU across 25 member states (with Denmark and Ireland as never-treated controls) to estimate the causal effect of the European Investigation Order (EIO) on crime, uses Eurostat’s ICCS data on fraud, drug offences, theft, homicide, and assault, and employs the Callaway-Sant’Anna staggered DiD estimator complemented with TWFE and a triple-difference. The targeting of cross-border crimes as primary outcomes and domestic crimes as placebos is consistent with the proposed research question. All key elements—transposition timing, data sources, and the focus on the conviction-probability channel—are present.

---

**Summary**

The paper studies whether the transposition of the European Investigation Order, which dramatically sped up cross-border evidence requests, deterred cross-border crime across the EU. Using staggered implementation timing and Eurostat ICCS crime data, the author finds null effects on fraud, drug offences, and theft via Callaway-Sant’Anna DiD estimates and shows that reported cross-border crime actually rose relative to domestic crime post-transposition, suggesting a detection rather than deterrence channel.

---

**Essential Points**

1. **Interpretation of the Triple-Difference**: The positive triple interaction is interpreted as improved detection, yet it could also reflect differential reporting trends or enforcement intensity unrelated to the EIO (e.g., broader EU-level initiatives that coincided with EIO transposition). The paper needs to provide more evidence that the triple-difference isolates the EIO’s detection channel rather than other concurrent factors. In particular, are there alternative data (e.g., case completion rates, mutual assistance requests) that change precisely at EIO transposition and align with the triple-difference coefficient? Without this, the claim that the EIO increased measured crime through better detection remains speculative.

2. **Placebo Heterogeneity**: The significant negative effect on serious assault in the placebo outcomes raises concerns about parallel trends and the validity of the comparison group. If treated countries also exhibit changes in a domestic crime with no theoretical link to the EIO, it suggests the identifying assumption may be violated. The paper must investigate why serious assault declines and demonstrate that it is not driving the cross-border result (e.g., by showing that the triple-difference is robust when using alternative domestic placebos or by controlling for other reforms/events coinciding with the EIO).

3. **Power and Precision**: While the null is presented as evidence against deterrence, the confidence intervals remain wide (e.g., ±0.11 for fraud). The paper should more thoroughly assess the minimum detectable effect and discuss whether the design is sufficiently powered to rule out economically meaningful deterrence effects. This includes clarifying how event-study dynamics behave and whether any heterogeneity (e.g., by pre-treatment crime levels or EU subregions) reveals patterns concealed by the aggregate ATT.

If these points cannot be adequately addressed, the paper’s causal claim about the absence of deterrence would be weakened.

---

**Suggestions**

1. **Strengthen Mechanism Evidence**  
   - Provide administrative evidence of detection improvements at transposition (e.g., increases in cross-border mutual legal assistance requests or reductions in average evidentiary processing time). This would substantiate the detection interpretation of the triple-difference coefficient. Eurojust/Europol reports or Commission monitoring summaries might include relevant metrics.  
   - Alternatively, examine whether the positive triple interaction occurs primarily in countries where the pre-EIO lag in cross-border evidence was longest, which would be consistent with the EIO unlocking previously stalled cases.

2. **Explore Pre-Trends and Event Studies**  
   - Include event-study graphs for the Callaway-Sant’Anna specification to demonstrate parallel trends for each cohort and each outcome. If some cohorts have trending pre-treatment paths, it would weaken the DID credibility.  
   - For the triple-difference, show category-specific pre-trends for cross-border versus domestic crimes to reassure readers that the differential trend only emerges post-treatment.

3. **Assess Heterogeneity**  
   - Exploit heterogeneity in the timing or enforcement capacity. For instance, examine whether countries transposing late (after infringement proceedings) experience different effects than early adopters.  
   - Split the sample by old versus new member states or by policing capacity to see if the null masks variation where enforcement cooperation matters more. Table A.1’s standardized effect sizes hint at differences between old/new MS; expanding this and linking it to mechanisms would add depth.

4. **Clarify the Role of Denmark and Ireland**  
   - Denmark and Ireland are the only never-treated controls, yet they have unique opt-out status. The paper should discuss whether their crime trends are comparable to the treated countries (e.g., plot their crime series). If the control group differs substantively, add robustness checks using alternative weighting schemes (e.g., consequence of limiting the sample to countries with similar baseline levels or trends).

5. **Address the Placebo Anomaly**  
   - Delve deeper into the assault result: is it driven by specific countries or years? Perhaps exclude assault from the DDD and replace it with another domestic crime (e.g., robbery) to verify that the positive triple interaction persists.  
   - If the assault decline reflects broader reporting improvements or concurrent policies, explicitly discuss those events and any controls used.

6. **Power Calculations and Interpretation**  
   - Report minimum detectable effects or “equivalence bounds” to clarify what effect sizes can be ruled out.  
   - Discuss the economic significance of the confidence intervals; for example, what would a 25% reduction in fraud imply for case outcomes or fiscal savings, and is that within or beyond the bounds excluded by the data?

7. **Presentation Enhancements**  
   - The robustness table mentions wild cluster bootstrap without presenting its results; either report the bootstrap estimates or omit the reference.  
   - Clarify how missing data cells (e.g., fewer than full coverage for fraud) are handled—are there imputed values, and does missingness correlate with transposition timing?

8. **Policy Implications**  
   - Expand the concluding discussion on what the findings imply for evaluating enforcement infrastructure. Suggest concrete metrics (case clearance rates, mutual assistance backlog) that policymakers should monitor beyond crime rates. This will strengthen the claim that detection gains deserve recognition even absent deterrence.

By addressing these points, the paper will offer a more nuanced interpretation of the EIO’s impact and reinforce the credibility of its empirical strategy.
